Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-09

Clinical Trial Update: Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for buprenorphine transdermal system in adults with chronic low back pain; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPRENORPHINE TRANSDERMAL SYSTEM (buprenorphine)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2010-09-09